Clinical Trial Update: HeartPhone Cancer Survivors Trial 2019 [Phase 1, Phase 2]

View source ↗

Summary

The HeartPhone Cancer Survivors Trial (Phase 1/2) sponsored by Penn State University was terminated; results have been posted for breast cancer, leukemia, and l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leukemia
• Lymphoma

Snippet

Sponsor: Penn State University | Conditions: Breast Cancer, Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-02-27